Ozempic, the brand name for semaglutide, is a GLP-1 receptor agonist used to treat type 2 diabetes and, more recently, obesity
Thus, it offers a possible treatment avenue for this difficult condition
Clear communication between all your healthcare providers ensures that each medication class supports rather than sabotages your health outcomes
However, understanding your genetic profile can support a more informed provider conversation about realistic goals, potential need for dose adjustment, and which combination strategy aligns with your individual physiology
She has personally experienced BPC-157s healing benefits twice
Compounded tirzepatide is supposed to contain the same active ingredient as the name-brand drugs, but it is not FDA approved, and its safety, quality, and potency are not verified